VectorXcellerator: OXB has selected the first programmes to move forward through VectorXcellerator, supporting earlier collaboration in advanced therapies.
OXB launches fast-track offering for AAV and lentiviral vector platforms, accelerating viral vector development and manufacture.
Visit our refreshed resource centre for the latest case studies, research posters and more.
